Pharmacogenomics for clinical trials of COVID-19 medicines: Why is this important now?

Basit Öğe Kaydı
dc.authoridSemra Şardaş / 0000-0001-5456-8636en_US
dc.authorscopusidSemra Şardaş / 7003286974
dc.authorwosidSemra Şardaş / J-2175-2018
dc.contributor.authorŞardaş, Semra
dc.contributor.authorÖzdemir, Vural
dc.date.accessioned2021-11-08T11:12:54Z
dc.date.available2021-11-08T11:12:54Z
dc.date.issued2021en_US
dc.departmentİstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümüen_US
dc.description.abstractHistorically, pharmacogenomics has origins in biochemical genetics in the 20th century and astute observations on unusual clinical responses to medicines. Extreme drug response phenotypes observed in the clinic have triggered molecular research on mechanisms of personto-person variations in drug safety and efficacy (Kalow, 1962; Ozdemir et al., 2009), and paved the way for the contemporary field of pharmacogenomics.en_US
dc.identifier.citationŞardaş, S., & Özdemir, V. (2021). Pharmacogenomics for Clinical Trials of COVID-19 Medicines: Why Is This Important Now?. Omics : a journal of integrative biology, 10.1089/omi.2021.0176. Advance online publication. https://doi.org/10.1089/omi.2021.0176en_US
dc.identifier.doi10.1089/omi.2021.0176en_US
dc.identifier.issue11en_US
dc.identifier.pmid34699259en_US
dc.identifier.scopus2-s2.0-85119487502en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.urihttps://doi.org/10.1089/omi.2021.0176
dc.identifier.urihttps://hdl.handle.net/20.500.12713/2213
dc.identifier.volume25en_US
dc.identifier.wosWOS:000713619200001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorŞardaş, Semra
dc.language.isoenen_US
dc.publisherOMICSen_US
dc.relation.ispartofJournal of Integrative Biologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePharmacogenomics for clinical trials of COVID-19 medicines: Why is this important now?en_US
dc.typeEditorialen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
14.pdf
Boyut:
55.99 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

PubMed İndeksli Yayınlar Koleksiyonu
Eczacılık Teknolojisi Bölümü Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu